Biblio Discovery — Demo Discovery Service

150 hasil

Menampilkan 1–20 · 0,33 detik · RSS

Jurnal

Onco

Scopus

ISSN 2673-7523 · MDPI AG · 150 artikel di indeks

  1. Artikel Jurnal Teks lengkap

    PROTACs in Oncology: Emerging Frontiers for Next-Generation Cancer Therapeutics

    Salahuddin; Renu Sharma; Mohamed Jawed Ahsan dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    PROTACs represent a cutting-edge approach to the discovery of innovative cancer therapies. By exploiting the cell’s ubiquitin–proteasome system, PROTACs induce the selective degradation of target proteins, providing a distinct advantage over conventional inhibitors that only block protein function…

  2. Artikel Jurnal Teks lengkap

    Microbiome-Based Therapeutics in Oncology: Expanding Indications Beyond C. difficile

    Ayham Al-Omari; Abdallah Kheshman; Peter Morkos dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    The intestinal microbiome has emerged as a clinically significant modulator of outcomes across multiple domains of cancer care. In hematopoietic stem cell transplantation (HSCT), loss of microbial diversity and depletion of short-chain fatty acid-producing commensals are independently associated…

  3. Artikel Jurnal Teks lengkap

    Hypoxia-Driven Alterations in the Tumour Microenvironment of Oral Cancer

    Suresh Shanmugham Reddy; Ashwin Ravichandran; Aishwarya Reddy dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Tumour hypoxia significantly influences disease advancement and treatment resistance in oral squamous cell carcinoma (OSCC). Hypoxia-inducible factor-1α (HIF-1α) is preserved when oxygen is lacking and triggers the expression of hypoxia-responsive genes that have roles in angiogenesis, metabolic…

  4. Artikel Jurnal Teks lengkap

    Involvement of Prolactin in Cancer Cell Migration

    Mariana G. Jiménez-Buendía; Jesús A. Lara-Reyes; María E. Hernández-Aguilar dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Prolactin (PRL) is a hormone synthesized by lactotrophs in the anterior pituitary gland. It is also produced by extrapituitary glands such as the prostate and breast, where it promotes growth. Notably, PRL also contributes to cancer development in these glands. PRL is known to stimulate cancer cell…

  5. Artikel Jurnal Teks lengkap

    Prognostic Value of Gleason Score for Overall Survival in Prostate Cancer: A Population-Based SEER Cohort Study

    Onyekachi Anya; Ogbonna Chikere; Progress Asoluka dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background/Objectives: Prostate cancer is biologically heterogeneous, and prognostic stratification informs the choice between definitive treatment and conservative management. Most evidence on the Gleason score addresses prostate cancer-specific mortality rather than survival from any cause. We…

  6. Artikel Jurnal Teks lengkap

    Implementation of Recent WHO Classification in Publications on Glioblastoma Research Using Multi-Omics Databases

    Nima Amouei; Mohamed Aljaberi; Jürgen Schlegel

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    (1) Background: Modifications to tumor classifications could fundamentally alter the foundation of research approaches. A concrete illustration of this issue is the actual WHO classification of tumors of the central nervous system, published in 2021. According to the WHO classification, GBM is an…

  7. Artikel Jurnal Teks lengkap

    The Medulloblastoma Microenvironment: Developmental Niches, Cellular Crosstalk and Therapeutic Opportunities

    John Jacob

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Medulloblastoma is increasingly best understood not simply as a cell-autonomous embryonal tumour, but as a family of molecularly and anatomically distinct diseases shaped by the developing cerebellum and posterior fossa. The four principal molecular subgroups—WNT, sonic hedgehog, Group 3 and Group…

  8. Artikel Jurnal Teks lengkap

    Epigenetic Reprogramming in Cancer Metastasis: From Histone Modifications to Therapeutic Vulnerabilities

    Prashant Pandey; Devika Tripathi; Kartik Mittal dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Cancer metastasis is the leading cause of cancer-related mortality, accounting for more than 90% of cancer deaths worldwide. However, the epigenetic mechanisms governing the metastatic cascade remain incompletely understood. Epigenetic reprogramming, including reversible changes in histone…

  9. Artikel Jurnal Teks lengkap

    Primary Renal Neuroendocrine Tumor in a Horseshoe Kidney: A Case Report of an Indolent Course

    Siham Mesmoudi; Taha Yassine Aaboudech; Sabrine Derqaoui dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background/Objectives: Primary renal NETs are exceptionally rare neoplasms that occur disproportionately in horseshoe kidneys. Their rarity and non-specific clinical and radiological features make preoperative diagnosis particularly challenging. Methods: Herein, we report the case of a 60-year-old…

  10. Artikel Jurnal Teks lengkap

    Cancer Therapy-Related Cutaneous Toxicities: Prognostic Biomarkers, Immunologic Endotypes, and Novel Therapeutic Strategies

    Federico Venturi; Emi Dika

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background/Objectives: Cutaneous adverse events (cAEs) are among the most common toxicities associated with modern anticancer therapies and can significantly affect quality of life, treatment adherence, and therapeutic outcomes. This narrative review aims to provide an updated overview of the…

  11. Artikel Jurnal Teks lengkap

    Nanotechnology-Driven Epigenetic Targeting: Tailoring Ovarian Cancer Therapeutics

    Vivek Pamula; Fernando Munguia; Siddharth Krishnan dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Epigenetic mechanisms play a crucial role in OC drug resistance, and emerging evidence suggests that dysregulated epigenetic modifications are among the key contributors to OC. Epigenetic agents, including DNA methyltransferase inhibitors, histone deacetylase inhibitors, and non-coding RNA-based…

  12. Artikel Jurnal Teks lengkap

    Reflex Sanger Sequencing Reveals a Rare UGT1A1 *28/*37 Compound Heterozygous Genotype After an Indeterminate Commercial Result in Late-Line Gastric Cancer

    Shuhei Suzuki; Yuka Kobayashi; Takashi Oizumi dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background/Objectives: Irinotecan is a key late-line agent in metastatic gastric cancer, but its dose-limiting toxicities—severe neutropenia and diarrhea—are strongly influenced by UGT1A1 promoter polymorphisms. Commercial genotyping kits in Japan routinely interrogate only the common *6 and *28…

  13. Artikel Jurnal Teks lengkap

    Antipsychotics for Cancer Treatment: Current Evidence

    Maria Vasiliki Benekou; Marios Lampros; Aikaterini Lianou dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Cancer is a leading health issue worldwide, affecting approximately 20 million people annually. Developing efficient chemotherapy agents for cancer treatment is a challenging, costly, and time-consuming process. Drug repurposing for cancer treatment provides an optimal alternative, as the…

  14. Artikel Jurnal Teks lengkap

    Transformation of NSCLC to SCLC: Insights into Molecular Alterations, Tumor Origin, and Therapeutic Advancements

    Anuska Mukherjee; Goutam Mukherjee; Subhadeep Das

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Small-cell lung cancer (SCLC) is a recalcitrant form of cancer, accounting for 15% of lung cancer cases worldwide. In recent years, the histological transformation from non-small-cell lung cancer (NSCLC) to SCLC has become a significant mechanism of acquired resistance, especially in patients…

  15. Artikel Jurnal Teks lengkap

    Rethinking Immunotherapy Drug Development in Head and Neck Squamous Cell Carcinoma: The Role of Biologic Context and Treatment Sequencing

    Sameeha Sajid; Muhammad Daud Abdullah; Aishwarya Hanspal dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Head and neck squamous cell carcinoma (HNSCC) remains a significant global health burden with limited survival improvement in locally advanced disease despite multimodal therapy. Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 pathway have demonstrated substantial clinical benefit in…

  16. Artikel Jurnal Teks lengkap

    The Gut–Nutrient–Genome Axis: A Host-Integrated Perspective on Genomic Instability in Cancer

    Robert H. Owen; Sivani Ravindran

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Genomic instability is a defining feature of cancer progression and therapeutic resistance, yet contemporary oncology interprets it largely through tumor-intrinsic genetic alterations, with less attention to the evolving host physiological context in which DNA damage accumulates and genome…

  17. Artikel Jurnal Teks lengkap

    Obesity as a Whole-Body Regulatory Disorder: A Systems Biology Framework for Metaflammation, Accelerated Aging, and Colorectal Cancer Risk

    Gaurav Dutta; Priyanka Mishra; Sidharth P. Mishra dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    Obesity is increasingly recognized as a complex systemic disorder rather than a simple consequence of excess energy intake and fat accumulation. This review presents a systems biology framework that examines how obesity-driven disruption of inter-organ communication networks contributes to chronic…

  18. Artikel Jurnal Teks lengkap

    The Role of Artificial Intelligence in the Management of Pancreatic Cancer: Current Evidence and Future Perspectives

    Afroditi Fotiadou; Ioannis Margaris; Kyriacos Evangelou dkk.

    Onco, Vol. 6 No. 3 · 2026 · Inggris · DOAJ Scopus

    (1) Background: Pancreatic ductal adenocarcinoma remains one of the most lethal malignancies due to late diagnosis, aggressive tumor biology, and limited therapeutic options. Artificial intelligence has emerged as a promising tool to improve detection, risk stratification, and treatment planning…

  19. Artikel Jurnal Teks lengkap

    Metabolic Reprogramming Following Mitochondrial Transfer Between IDH2-Mutant Chondrosarcoma Cells and a Normal B-Cell Line

    Caleb Wyckoff; Christopher Osgood; Ellen Jing dkk.

    Onco, Vol. 6 No. 1 · 2026 · Inggris · DOAJ Scopus

    Background/Objectives: Chondrosarcoma, glioblastoma, acute myeloid leukemia, chronic lymphocytic leukemia, and cholangiocarcinoma cancers all contain mutations in the gene isocitrate dehydrogenase 2 (IDH2). The mutant IDH2 enzyme metabolizes alpha-ketoglutarate (αKG) into the potent oncometabolite…

  20. Artikel Jurnal Teks lengkap

    The Male Predominance in HBV-Related Hepatocellular Carcinoma: Unraveling the Axis of Androgen Receptor, Viral Replication, and Immune Evasion via NKG2D Ligands

    Koji Takahashi; Takaaki Ikegami; Arisa Kato dkk.

    Onco, Vol. 6 No. 1 · 2026 · Inggris · DOAJ Scopus

    Hepatocellular carcinoma (HCC) exhibits a striking male predominance, particularly in Hepatitis B Virus (HBV) endemic regions. While lifestyle factors and estrogen protection are traditional explanations, they fail to fully account for this disparity. This review elucidates the molecular mechanisms…